Aboli Girme

Ayurveda botanicals in COVID-19 management: An in silico multi-target approach

Swapnil Borse, Manali Joshi, Akash Saggam et al. · PLoS ONE · 2021 · 96 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Investigating 11 Withanosides and Withanolides by UHPLC–PDA and Mass Fragmentation Studies from Ashwagandha (<i>Withania somnifera</i>)

Aboli Girme, Ganesh Saste, Sandeep Pawar et al. · ACS Omega · 2020 · 74 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)

Siddharth J. Modi, Anshuly Tiwari, Chetana Ghule et al. · Molecules · 2022 · 61 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis

V. G. Vaidya, Ninad Naik, Gayatri Ganu et al. · Journal of Ethnopharmacology · 2023 · 36 citations

Medicine, Pharmacokinetics, Pharmacology +5

Assessment of Curcuma longa extract for adulteration with synthetic curcumin by analytical investigations

Aboli Girme, Ganesh Saste, Arun Kumar Balasubramaniam et al. · Journal of Pharmaceutical and Biomedical Analysis · 2020 · 34 citations

Pharmacy, Medicinal Chemistry, Pharmaceutical Analysis +13